跳至主要内容
临床试验/NCT03550456
NCT03550456已完成不适用

Diagnostics of the Quality of Life With Exercise Induced Asthma (EIA) and Exercise Induced Laryngeal Obstruction (EILO)

Johann Wolfgang Goethe University Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Quality of life in subjects with exercise induced asthma and exercise induced laryngeal obstruction

研究概览

简要总结

The purpose of this study is to investigate the quality of life of subjects suffering from dyspnoea while exercising and quantify the number of diagnoses of Exercise induced Asthma (EIA) and Exercise induced laryngeal obstruction (EILO) in our outpatient clinic using an exercise-challenge in a cold-chamber and an exercise-challenge with continuous laryngoscopy.

详细描述

In this study investigators want to characterize and investigate the quality of life of all patients consulting the outpatient clinic for pediatric pulmonology suffering from dyspnoea while exercising.

Besides standard diagnostics (bodyplethysmograph, spirometry, exhaled NO, skin prick test) subjects will take part in an exercise-challenge in a cold chamber at 2-4°C. Subjects showing symptoms of exercise-induced asthma will get a treatment with ICS/LABA for six weeks. All Patients should fill out a symptom diary. On suspicion of an EILO, subjects not showing symptoms in the first exercise-challenge in the cold chamber and all subjects without improvement after EIA treatment will take part in a second exercise-challenge in the cold chamber with continuous laryngoscopy.

If EILO is proved by laryngoscopy, speech therapy is recommended. To investigate the symptoms and the quality of life of these patients, all patients and there parents should answer symptom and quality of life questionnaires (Child Behavior Checklist (CBCL/4-18), Youth Self-Report (YSR 11-18), Asthma Control Test, (ACT) Dyspnea Index (DI)) at every visit.

There are yearly follow ups of these patients for five years in order to collect long-range prognosis.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
8 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者
否

入选标准

  • •written agreement
  • •age: >=8 and <= 18
  • •exercise induced dyspnea
  • •at least two training session per week
  • •lung function before physical exercise FVC >= 75% and FEV1 >= 70%

排除标准

  • •age <8 and >18
  • •lung function: forced vital capacity (FVC) < 75% and forced expiratory pressure in one second (FEV1) < 70%
  • •inability to understand the range oft the study
  • •chronic asthma with systemic cortisone therapy
  • •chronic asthma with high dose cortisone inhalation >500 micrograms fluticasone equivalent
  • •intake of long acting beta-agonists (LABA) 48 h before examination
  • •acute severe infection (pneumonia) within the last 4 weeks
  • •intake of leukotriene-antagonists 48h before examination
  • •other chronic diseases or infections (HIV, Tbc)
  • •pregnancy

结局指标

主要结局

Quality of life in subjects with exercise induced asthma and exercise induced laryngeal obstruction

时间窗: 5 years

The primary endpoint is the quality of life of all subjects with EIA and EILO assessed by questionnaires (Child Behavior Checklist (CBCL/4-18) for parents and Youth Self-Report (YSR 11-18) for adolescents) at the time of diagnosis and after therapy in accordance with the diagnosis with ICS/LABA combination or speech therapy. Both questionnaires are almost identical and contain 120 items (CBCL/4-18) and 119 items (YSR), respectively, in eight different categories: anxious/depressed, withdrawn/depressed, somatic complaints, social problems, thought problems, attention problems, rule-breaking behavior, and aggressive behavior. Answers to each item are coded on a 3-point Likert-scale, 0 = not true, 1 = somewhat or sometimes true, 2 = very true or often true. Raw scores are transformed into T-scores to allow comparison with children from the same gender and age.

次要结局

  • Speech therapy(5 years)
  • Symptoms of EIA and EILO(5 years)
  • Prevalence(1 year)
  • Carbon dioxide(5 years)

研究者

发起方
Johann Wolfgang Goethe University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Johannes Schulze MD

Prof.

Johann Wolfgang Goethe University Hospital

研究点 (1)

Loading locations...

相似试验